ER maleate is a novel anticancer agent in oral cancer: implications for cancer therapy.
Oncotarget
; 7(13): 17162-81, 2016 Mar 29.
Article
in En
| MEDLINE
| ID: mdl-26934445
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Mouth Neoplasms
/
Carcinoma, Squamous Cell
/
Proto-Oncogene Proteins
/
Protein Serine-Threonine Kinases
/
Cell Cycle Proteins
/
Syk Kinase
/
Head and Neck Neoplasms
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Limits:
Adult
/
Aged
/
Aged80
/
Animals
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Oncotarget
Year:
2016
Document type:
Article
Affiliation country:
Canada
Country of publication:
United States